SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-041389
Filing Date
2024-05-09
Accepted
2024-05-09 17:25:14
Documents
13
Period of Report
2024-04-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0205666-8k_lucy.htm   iXBRL 8-K 26493
  Complete submission text file 0001213900-24-041389.txt   200751

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lsdi-20240425.xsd EX-101.SCH 3033
3 XBRL LABEL FILE lsdi-20240425_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE lsdi-20240425_pre.xml EX-101.PRE 22371
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0205666-8k_lucy_htm.xml XML 3680
Mailing Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6
Business Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6 778-410-5195
Lucy Scientific Discovery, Inc. (Filer) CIK: 0001865127 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41616 | Film No.: 24932010
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)